Literature DB >> 3488551

Perturbation of the human T-cell antigen receptor-T3 complex leads to the production of inositol tetrakisphosphate: evidence for conversion from inositol trisphosphate.

S J Stewart, V Prpic, F S Powers, S B Bocckino, R E Isaacks, J H Exton.   

Abstract

Antibodies directed against the T-cell antigen receptor-T3 complex mimic antigen and lead to cellular changes consistent with activation. When cells of the human T-cell line Jurkat were stimulated with a monoclonal antibody directed against T3, inositol phosphates were produced. In addition to inositol trisphosphate, which is the product of phosphatidylinositol bisphosphate cleavage, a second inositol polyphosphate was formed. This compound was more polar than inositol trisphosphate but less polar than inositol pentakisphosphate. It cochromatographed with inositol tetrakisphosphate from ostrich erythrocytes. In permeabilized Jurkat cells, this compound was shown to be formed from inositol 1,4,5-trisphosphate, but only in the presence of ATP, and 32P was incorporated into it from [gamma-32P]ATP. There also was coincident formation of inositol 1,3,4-trisphosphate. We conclude that the more polar compound is inositol tetrakisphosphate, which is formed by phosphorylation of inositol 1,4,5-trisphosphate and may be the precursor of inositol 1,3,4-trisphosphate.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3488551      PMCID: PMC386446          DOI: 10.1073/pnas.83.16.6098

Source DB:  PubMed          Journal:  Proc Natl Acad Sci U S A        ISSN: 0027-8424            Impact factor:   11.205


  29 in total

1.  Studies on avian erythrocyte metabolism. Inositol tetrakisphosphate: the major phosphate compound in the erythrocytes of the ostrich (Struthio camelus camelus).

Authors:  R Isaacks; D Harkness; R Sampsell; J Adler; S Roth; C Kim; P Goldman
Journal:  Eur J Biochem       Date:  1977-08-01

Review 2.  Receptors and phosphoinositide-generated second messengers.

Authors:  L E Hokin
Journal:  Annu Rev Biochem       Date:  1985       Impact factor: 23.643

3.  The enzymatic preparation of [alpha-(32)P]nucleoside triphosphates, cyclic [32P] AMP, and cyclic [32P] GMP.

Authors:  T F Walseth; R A Johnson
Journal:  Biochim Biophys Acta       Date:  1979-03-28

4.  Metabolism of inositol phosphates. II. Biosynthesis of inositol polyphosphates in germinating seeds of Phaseolus aureus.

Authors:  N C Mandal; B B Biswas
Journal:  Indian J Biochem       Date:  1970-03

5.  OKT3: a monoclonal anti-human T lymphocyte antibody with potent mitogenic properties.

Authors:  J P Van Wauwe; J R De Mey; J G Goossens
Journal:  J Immunol       Date:  1980-06       Impact factor: 5.422

6.  myo-Inositol uptake and metabolism in isolated rat liver cells.

Authors:  V Prpić; P F Blackmore; J H Exton
Journal:  J Biol Chem       Date:  1982-10-10       Impact factor: 5.157

7.  Isolation and assay of red-cell inositol polyphosphates.

Authors:  G R Bartlett
Journal:  Anal Biochem       Date:  1982-08       Impact factor: 3.365

8.  The inositol trisphosphate phosphomonoesterase of the human erythrocyte membrane.

Authors:  C P Downes; M C Mussat; R H Michell
Journal:  Biochem J       Date:  1982-04-01       Impact factor: 3.857

9.  Metabolism of inositol 1,4,5-trisphosphate and inositol 1,3,4-trisphosphate in rat parotid glands.

Authors:  R F Irvine; E E Anggård; A J Letcher; C P Downes
Journal:  Biochem J       Date:  1985-07-15       Impact factor: 3.857

10.  Biochemical and biological characterization of lymphocyte regulatory molecules. V. Identification of an interleukin 2-producing human leukemia T cell line.

Authors:  S Gillis; J Watson
Journal:  J Exp Med       Date:  1980-12-01       Impact factor: 14.307

View more
  11 in total

Review 1.  Regulation of immune cell development through soluble inositol-1,3,4,5-tetrakisphosphate.

Authors:  Karsten Sauer; Michael P Cooke
Journal:  Nat Rev Immunol       Date:  2010-04       Impact factor: 53.106

Review 2.  An assessment of phosphoinositide hydrolysis in antigenic signal transduction in lymphocytes.

Authors:  S L King
Journal:  Immunology       Date:  1988-09       Impact factor: 7.397

3.  Bacterial toxins affect early events of T lymphocyte activation.

Authors:  S J Stewart; V Prpic; J A Johns; F S Powers; S E Graber; J T Forbes; J H Exton
Journal:  J Clin Invest       Date:  1989-01       Impact factor: 14.808

Review 4.  Inositol-1,4,5-trisphosphate 3-kinase-A (ITPKA) is frequently over-expressed and functions as an oncogene in several tumor types.

Authors:  Sabine Windhorst; Kai Song; Adi F Gazdar
Journal:  Biochem Pharmacol       Date:  2017-04-02       Impact factor: 5.858

5.  The T-cell antigen receptor regulates sustained increases in cytoplasmic free Ca2+ through extracellular Ca2+ influx and ongoing intracellular Ca2+ mobilization.

Authors:  J B Imboden; A Weiss
Journal:  Biochem J       Date:  1987-11-01       Impact factor: 3.857

6.  Formation and metabolism of inositol 1,4,5-trisphosphate in human platelets.

Authors:  J L Daniel; C A Dangelmaier; J B Smith
Journal:  Biochem J       Date:  1987-08-15       Impact factor: 3.857

7.  Regulation of inositol 1,4,5-trisphosphate kinase activity after stimulation of human T cell antigen receptor.

Authors:  J B Imboden; G Pattison
Journal:  J Clin Invest       Date:  1987-05       Impact factor: 14.808

8.  Micro-injection of inositol 1,3,4,5-tetrakisphosphate activates sea urchin eggs by a mechanism dependent on external Ca2+.

Authors:  R F Irvine; R M Moor
Journal:  Biochem J       Date:  1986-12-15       Impact factor: 3.857

9.  Phosphoinositide and inositol phosphate analysis in lymphocyte activation.

Authors:  Karsten Sauer; Yina Hsing Huang; Hongying Lin; Mark Sandberg; Georg W Mayr
Journal:  Curr Protoc Immunol       Date:  2009-11

10.  Activation of phospholipase D: a signaling system set in motion by perturbation of the T lymphocyte antigen receptor/CD3 complex.

Authors:  S J Stewart; G R Cunningham; J A Strupp; F S House; L L Kelley; G S Henderson; J H Exton; S B Bocckino
Journal:  Cell Regul       Date:  1991-10
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.